Mimicry of microbially-derived butyrate reveals templates for potent intestinal epithelial HIF stabilizers

References

• Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189–16. doi:10.1080/19490976.2015.1134082.
   PubMed Web of Science ®Google Scholar
• Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:227. doi:10.3389/fimmu.2019.01486.
   PubMed Web of Science ®Google Scholar
• Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S. Short chain fatty acids and its producing organisms: an overlooked therapy for IBD? EBioMedicine. 2021;66:103293. doi:10.1016/j.ebiom.2021.103293.
   PubMed Web of Science ®Google Scholar
• Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81(3):1031–1064. doi:10.1152/physrev.2001.81.3.1031.
   PubMed Web of Science ®Google Scholar
• Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221–1227. doi:10.1136/gut.28.10.1221.
   PubMed Web of Science ®Google Scholar
• Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev. 2010;23(2):366–384. doi:10.1017/s0954422410000247.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang J, He T, Becker S, Zhang G, Li D, Ma X. Butyrate: a Double-edged sword for health? Adv Nutr. 2018;9(1):21–29. doi:10.1093/advances/nmx009.
   PubMed Web of Science ®Google Scholar
• Ornelas A, Dowdell AS, Lee JS, Colgan SP. Microbial metabolite regulation of epithelial cell-cell Interactions and barrier function. Cells. 2022;11(6):944. doi:10.3390/cells11060944.
   PubMed Web of Science ®Google Scholar
• Wang RX, Lee JS, Campbell EL, Colgan SP. Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin. Proc Natl Acad Sci. 2020;117(21):11648–11657. doi:10.1073/pnas.1917597117.
   PubMed Web of Science ®Google Scholar
• Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133(7):2485S–2493S. doi:10.1093/jn/133.7.2485s.
   PubMed Web of Science ®Google Scholar
• de Clercq NC, Groen AK, Romijn JA, Nieuwdorp M. Gut microbiota in obesity and undernutrition. Adv Nutr. 2016;7(6):1080–1089. doi:10.3945/an.116.012914.
   PubMed Web of Science ®Google Scholar
• Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10(7):1775. doi:10.3390/cells10071775.
   PubMed Web of Science ®Google Scholar
• Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91–119. doi:10.1016/b978-0-12-800100-4.00003-9.
   PubMed Web of Science ®Google Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2007;27(2):104–119. doi:10.1111/j.1365-2036.2007.03562.x.
   PubMed Web of Science ®Google Scholar
• Kelly C, Zheng L, Campbell E, Saeedi B, Scholz C, Bayless A, Wilson K, Glover L, Kominsky D, Magnuson A, et al. Crosstalk between microbiota-derived Short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host & Microbe. 2015;17(5):662–671. doi:10.1016/j.chom.2015.03.005.
   PubMed Web of Science ®Google Scholar
• Wang RX, Henen MA, Lee JS, Vögeli B, Colgan SP. Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor. Gut Microbes. 2021;13(1):1938380. doi:10.1080/19490976.2021.1938380.
   PubMed Web of Science ®Google Scholar
• Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov. 2003;2(10):803–811. doi:10.1038/nrd1199.
   PubMed Web of Science ®Google Scholar
• Palazon A, Goldrath Ananda W, Nizet V, Johnson Randall S. HIF transcription factors, inflammation, and Immunity. Immunity. 2014;41(4):518–528. doi:10.1016/j.immuni.2014.09.008.
   PubMed Web of Science ®Google Scholar
• Kelly CJ, Glover LE, Campbell EL, Kominsky DJ, Ehrentraut SF, Bowers BE, Bayless AJ, Saeedi BJ, Colgan SP. Fundamental role for HIF-1alpha in constitutive expression of human beta defensin-1. Mucosal Immunol. 2013;6(6):1110–1118. doi:10.1038/mi.2013.6.
   PubMed Web of Science ®Google Scholar
• Fong GH, Takeda K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 2008;15(4):635–641. doi:10.1038/cdd.2008.10.
   PubMed Web of Science ®Google Scholar
• Kaelin WG. PROLINE HYDROXYLATION and GENE EXPRESSION. Annu Rev Biochem. 2005;74(1):115–128. doi:10.1146/annurev.biochem.74.082803.133142.
   PubMedGoogle Scholar
• Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399–408. doi:10.1016/j.cell.2012.01.021.
   PubMed Web of Science ®Google Scholar
• Kaelin WG, Ratcliffe PJ. Oxygen sensing by Metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30(4):393–402. doi:10.1016/j.molcel.2008.04.009.
   PubMed Web of Science ®Google Scholar
• Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21(9):793–798. doi:10.1136/gut.21.9.793.
   PubMed Web of Science ®Google Scholar
• Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE, Kominsky DJ, Magnuson A, et al. Crosstalk between microbiota-derived Short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17(5):662–671. doi:10.1016/j.chom.2015.03.005.
   PubMed Web of Science ®Google Scholar
• Mani S. Microbial metabolite mimicry: one step closer to drug discovery. Oncotarget. 2020;11(19):1680. doi:10.18632/oncotarget.27591.
   PubMedGoogle Scholar
• Dvořák Z, Kopp F, Costello CM, Kemp JS, Li H, Vrzalová A, Štěpánková M, Bartoňková I, Jiskrová E, Poulíková K, et al. Targeting the pregnane X receptor using microbial metabolite mimicry. EMBO Mol Med. 2020;12(4):e11621. doi:10.15252/emmm.201911621.
   PubMed Web of Science ®Google Scholar
• Nuzzo A, Brown JR. Microbiome metabolite mimics accelerate drug discovery. Trends Mol Med. 2020;26(5):435–437. doi:10.1016/j.molmed.2020.03.006.
   PubMed Web of Science ®Google Scholar
• Parajuli P, Gokulan K, Khare S. Preclinical in vitro model to assess the changes in permeability and cytotoxicity of polarized intestinal epithelial cells during exposure mimicking oral or intravenous routes: an example of arsenite exposure. Int J Mol Sci. 2022;23(9):4851. doi:10.3390/ijms23094851.
   PubMed Web of Science ®Google Scholar
• Heikal L, Ghezzi P, Mengozzi M, Ferns G. Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo. Mol Med. 2018;24(1):22. doi:10.1186/s10020-018-0026-5.
   PubMedGoogle Scholar
• Zhang Y, Liu D, Hu H, Zhang P, Xie R, Cui W. HIF-1α/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury. Biomed Pharmacother. 2019;120:109464. doi:10.1016/j.biopha.2019.109464.
   PubMed Web of Science ®Google Scholar
• Dowdell AS, Cartwright IM, Kitzenberg DA, Kostelecky RE, Mahjoob O, Saeedi BJ, Welch N, Glover LE, Colgan SP. Essential role for epithelial HIF-mediated xenophagy in control of salmonella infection and dissemination. Cell Rep. 2022;40(13):111409. doi:10.1016/j.celrep.2022.111409.
   PubMed Web of Science ®Google Scholar
• Potter C, Harris AL. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle. 2004;3(2):164–167. doi:10.4161/cc.3.2.618.
   PubMed Web of Science ®Google Scholar
• Bagiyan GA, Koroleva IK, Soroka NV, Ufimtsev AV. Ufimtsev AV. Russian Chem Bulletin. 2003;52(5):1135–1141. doi:10.1023/a:1024761324710.
   Google Scholar
• Beinert H, Kennedy MC, Stout CD. Aconitase as iron−Sulfur protein, Enzyme, and iron-regulatory protein. Chem Rev. 1996;96(7):2335–2374. doi:10.1021/cr950040z.
   PubMed Web of Science ®Google Scholar
• Dowdell AS, Cartwright IM, Goldberg MS, Kostelecky R, Ross T, Welch N, Glover LE, Colgan SP, Yap A. The HIF target ATG9A is essential for epithelial barrier function and tight junction biogenesis. Mol Biol Cell. 2020;31(20):2249–2258. doi:10.1091/mbc.e20-05-0291.
   PubMed Web of Science ®Google Scholar
• Glover LE, Bowers BE, Saeedi B, Ehrentraut SF, Campbell EL, Bayless AJ, Dobrinskikh E, Kendrick AA, Kelly CJ, Burgess A, et al., Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis, Proc Natl Acad Sci U S A. 2013;110(49):19820–19825. Epub 2013 Nov 18. doi:10.1073/pnas.1302840110.
   PubMed Web of Science ®Google Scholar
• Persson HL, Svensson AI, Brunk UT. A-Lipoic acid and a-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis. Redox Report. 2001;6(5):327–334. doi:10.1179/135100001101536472.
   PubMed Web of Science ®Google Scholar
• Flora SJS. Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxid Med Cell Longev. 2009;2(4):191–206. doi:10.4161/oxim.2.4.9112.
   PubMed Web of Science ®Google Scholar
• Glover LE, Colgan SP. Epithelial barrier regulation by Hypoxia-Inducible Factor. Ann Am Thorac Soc. 2017;14(Supplement_3):S233–S236. doi:10.1513/AnnalsATS.201608-610MG.
   PubMedGoogle Scholar
• Zheng L, Kelly CJ, Battista KD, Schaefer R, Lanis JM, Alexeev EE, Wang RX, Onyiah JC, Kominsky DJ, Colgan SP. Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of claudin-2. J Immunol. 2017;199(8):2976–2984. doi:10.4049/jimmunol.1700105.
   PubMed Web of Science ®Google Scholar
• Curtis VF, Ehrentraut SF, Campbell EL, Glover LE, Bayless A, Kelly CJ, Kominsky DJ, Colgan SP. Stabilization of HIF through inhibition of cullin-2 neddylation is protective in mucosal inflammatory responses. FASEB J. 2015;29(1):208–215. doi:10.1096/fj.14-259663.
   PubMed Web of Science ®Google Scholar
• Haase VH. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev. 2013;27(1):41–53. doi:10.1016/j.blre.2012.12.003.
   PubMed Web of Science ®Google Scholar
• Marchbank T, Mahmood A, Harten S, Maxwell PH, Playford RJ. Dimethyloxalyglycine stimulates the early stages of gastrointestinal repair processes through VEGF-dependent mechanisms. Lab Invest. 2011;91(12):1684–1694. doi:10.1038/labinvest.2011.129.
   PubMed Web of Science ®Google Scholar
• Song YR, You SJ, Lee Y-M, Chin HJ, Chae D-W, Oh YK, Joo KW, Han JS, Na KY. Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transpl. 2009;25(1):77–85. doi:10.1093/ndt/gfp454.
   PubMed Web of Science ®Google Scholar
• Colgan SP, Wang RX, Hall CHT, Bhagavatula G, Lee JS. Revisiting the “starved gut” hypothesis in inflammatory bowel disease. Immunometabolism (Cobham). 2023;5(1):e0016. doi:10.1097/IN9.0000000000000016.
   PubMedGoogle Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104–119. doi:10.1111/j.1365-2036.2007.03562.x.
   PubMed Web of Science ®Google Scholar
• Machiels K, Joossens M, Sabino J, Preter VD, Arijs I, Eeckhaut V, Ballet V, Claes K, Immerseel FV, Verbeke K, et al. A decrease of the butyrate-producing species roseburia hominis and faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63(8):1275–1283. doi:10.1136/gutjnl-2013-304833.
   PubMed Web of Science ®Google Scholar
• Saeedi BJ, Kao DJ, Kitzenberg DA, Dobrinskikh E, Schwisow KD, Masterson JC, Kendrick AA, Kelly CJ, Bayless AJ, Kominsky DJ, et al. HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity. Mol Biol Cell. 2015;26(12):2252–2262. doi:10.1091/mbc.E14-07-1194.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan SK, Shah YM. Role of intestinal HIF-2α in health and disease. Annu Rev Physiol. 2016;78(1):301–325. doi:10.1146/annurev-physiol-021115-105202.
   PubMedGoogle Scholar
• Cummins EP, Crean D. Hypoxia and inflammatory bowel disease. Microbes Infect. 2017;19(3):210–221. doi:10.1016/j.micinf.2016.09.004.
   PubMed Web of Science ®Google Scholar
• Lei X, Teng W, Fan Y, Zhu Y, Yao L, Li Y, Zhu S, Pileggi M. The protective effects of HIF-1α activation on sepsis induced intestinal mucosal barrier injury in rats model of sepsis. PloS One. 2022;17(5):e0268445. doi:10.1371/journal.pone.0268445.
   PubMed Web of Science ®Google Scholar
• Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest. 2004;114(8):1098–1106. doi:10.1172/JCI200421086.
   PubMed Web of Science ®Google Scholar
• Taylor CT, Scholz CC. The effect of HIF on metabolism and immunity. Nat Rev Nephrol. 2022;18(9):573–587. doi:10.1038/s41581-022-00587-8.
   PubMed Web of Science ®Google Scholar
• DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and Animal models. Inflamm Bowel Dis. 2016;22(5):1137–1150. doi:10.1097/mib.0000000000000750.
   PubMed Web of Science ®Google Scholar
• Gasaly N, Hermoso MA, Gotteland M. Butyrate and the fine-tuning of colonic homeostasis: implication for inflammatory bowel diseases. Int J Mol Sci. 2021;22(6):3061. doi:10.3390/ijms22063061.
   PubMed Web of Science ®Google Scholar
• Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177–185. doi:10.1016/j.cmet.2006.02.002.
   PubMed Web of Science ®Google Scholar
• Lu CW, Lin SC, Chen KF, Lai YY, Tsai SJ. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem. 2008;283(42):28106–28114. doi:10.1074/jbc.M803508200.
   PubMed Web of Science ®Google Scholar
• Li H, Ranhotra HS, Mani S, Dvořák Z, Sokol H, Müller R. Human microbial metabolite mimicry as a strategy to expand the chemical space of potential drugs. Drug Discov Today. 2020;25(9):1575–1579. doi:10.1016/j.drudis.2020.06.007.
   PubMed Web of Science ®Google Scholar
• Liao S-Y, Lerman MI, Stanbridge EJ. Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development. BMC Dev Biol. 2009;9(1):22. doi:10.1186/1471-213X-9-22.
   PubMedGoogle Scholar
• Ulrich K, Jakob U. The role of thiols in antioxidant systems. Free Radic Biol Med. 2019;140:14–27. doi:10.1016/j.freeradbiomed.2019.05.035.
   PubMed Web of Science ®Google Scholar
• Van Der Schoor SRD, Reeds PJ, Stoll B, Henry JF, Rosenberger JR, Burrin DG, Van Goudoever JB. The high metabolic cost of a functional gut. Gastroenterology. 2002;123(6):1931–1940. doi:10.1053/gast.2002.37062.
   PubMed Web of Science ®Google Scholar
• Glover LE, Colgan SP. Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology. 2011;140(6):1748–1755. doi:10.1053/j.gastro.2011.01.056.
   PubMed Web of Science ®Google Scholar
• Steiner CA, Cartwright IM, Taylor CT, Colgan SP. Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis. Am J Physiol-Cell Ph. 2022;323(3):C866–C878. doi:10.1152/ajpcell.00227.2022.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Ghosh S, Panes J, Schreiber S, D’Haens G, Tanida S, Siffledeen J, Enejosa J, Zhou W, Othman AA, et al. Efficacy of upadacitinib in a randomized trial of patients with active ulcerative colitis. Gastroenterology. 2020;158(8):2139–2149 e2114. doi:10.1053/j.gastro.2020.02.030.
   PubMed Web of Science ®Google Scholar
• D’Haens G, Panes J, Louis E, Lacerda A, Zhou Q, Liu J, Loftus EV Jr. Upadacitinib was Efficacious and well-tolerated over 30 months in patients with Crohn’s disease in the CELEST Extension study. Clin Gastroenterol Hepatol. 2021;20(10):2337–2346.e3. doi:10.1016/j.cgh.2021.12.030.
   PubMed Web of Science ®Google Scholar
• Peterson MD, Mooseker MS. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci. 1992;102(Pt 3):581–600. doi:10.1242/jcs.102.3.581.
   PubMedGoogle Scholar
• Campbell EL, Bruyninckx WJ, Kelly CJ, Glover LE, McNamee EN, Bowers BE, Bayless AJ, Scully M, Saeedi BJ, Golden-Mason L, et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity. 2014;40(1):66–77. doi:10.1016/j.immuni.2013.11.020.
   PubMed Web of Science ®Google Scholar